Parkside Financial Bank & Trust’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-10
| Closed | – | – | 2034 |
|
2022
Q3 | $0 | Sell |
10
-91
| -90% | – | ﹤0.01% | 1893 |
|
2022
Q2 | $6K | Buy |
101
+32
| +46% | +$1.9K | ﹤0.01% | 1177 |
|
2022
Q1 | $6K | Buy |
69
+12
| +21% | +$1.04K | ﹤0.01% | 1231 |
|
2021
Q4 | $12K | Buy |
57
+56
| +5,600% | +$11.8K | ﹤0.01% | 966 |
|
2021
Q3 | $0 | Sell |
1
-3
| -75% | – | ﹤0.01% | 1818 |
|
2021
Q2 | $1K | Buy |
4
+1
| +33% | +$250 | ﹤0.01% | 1646 |
|
2021
Q1 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 1622 |
|
2020
Q4 | – | Sell |
-3
| Closed | -$1K | – | 1648 |
|
2020
Q3 | $1K | Sell |
3
-1
| -25% | -$333 | ﹤0.01% | 1382 |
|
2020
Q2 | $1K | Sell |
4
-2
| -33% | -$500 | ﹤0.01% | 1347 |
|
2020
Q1 | $1K | Buy |
6
+4
| +200% | +$667 | ﹤0.01% | 1294 |
|
2019
Q4 | $1K | Sell |
2
-1
| -33% | -$500 | ﹤0.01% | 1435 |
|
2019
Q3 | $1K | Sell |
3
-1
| -25% | -$333 | ﹤0.01% | 1401 |
|
2019
Q2 | $2K | Buy |
4
+1
| +33% | +$500 | ﹤0.01% | 1194 |
|
2019
Q1 | $2K | Buy |
3
+1
| +50% | +$667 | ﹤0.01% | 1184 |
|
2018
Q4 | $1K | Buy |
2
+1
| +100% | +$500 | ﹤0.01% | 1264 |
|
2018
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 1320 |
|
2018
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 1303 |
|
2018
Q1 | $2K | Sell |
1
-5
| -83% | -$10K | ﹤0.01% | 1034 |
|
2017
Q4 | $5K | Hold |
6
| – | – | ﹤0.01% | 857 |
|
2017
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 993 |
|
2017
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 1001 |
|
2017
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 982 |
|
2016
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 1158 |
|